<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02839083</url>
  </required_header>
  <id_info>
    <org_study_id>MD âˆ• 153</org_study_id>
    <nct_id>NCT02839083</nct_id>
  </id_info>
  <brief_title>Pecs II Block as Alternative for Paravertebral Block in Modified Radical Mastectomy</brief_title>
  <official_title>Thoracic Paravertebral Block Versus Pecs II Block for Perioperative Analgesia in Modified Radical Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breast surgeries are usually associated with significant postoperative pain. Suitability of&#xD;
      analgesic technique after breast surgery is always questionable. The aim of this study is to&#xD;
      compare US guided Pecs II block versus thoracic paravertebral block performed by US guidance&#xD;
      as regards to potential complications and analgesic efficacy of both techniques in the first&#xD;
      24 h after modified radical mastectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Various modalities have been used for perioperative pain management in relevance to breast&#xD;
      surgery. Thoracic epidural and paravertebral blocks (PVB) became the gold standard techniques&#xD;
      to achieve this goal. However, both techniques may be associated with devastating&#xD;
      complications such as spinal cord injury, total spinal anesthesia, inadvertent intravascular&#xD;
      injection and pneumothorax.&#xD;
&#xD;
      On the other hand, the advancement of ultrasound (US) technology and our ability to visualize&#xD;
      the pleura and other structures in and around the paravertebral space has increased interest&#xD;
      in performing thoracic paravertebral blocks guided by US.&#xD;
&#xD;
      &quot;Pecs&quot; block is a less invasive procedure involving US guided interfascial injections has&#xD;
      been suggested as potential alternative analgesic technique. The Pecs I block was initially&#xD;
      described by Blanco for minor breast surgery. A year later, on 2012, he described a Pecs II&#xD;
      block or &quot;modified Pecs block&quot; for breast surgery involving the axilla.&#xD;
&#xD;
      The Pecs I block targets the medial pectoral nerve (MPN) from C8 and T1 and the lateral&#xD;
      pectoral nerve (LPN) from C5, C6, and C7. These nerves arise from the medial and lateral&#xD;
      cords of the brachial plexus, respectively, and innervate the pectoralis muscles.&#xD;
&#xD;
      The Pecs II block targets the T2-6 intercostal nerves, the long thoracic nerve which supplies&#xD;
      the serratus anterior, and the thoracodorsal nerve which supplies the latissimus dorsi.&#xD;
      Potential complications include accidental intravascular injection and pneumothorax.&#xD;
&#xD;
      The easily identifiable landmarks allow this block to provide a simple alternative to&#xD;
      paravertebral and neuraxial blocks for breast surgery. The block produces excellent analgesia&#xD;
      and can be used as a rescue block in cases with patchy or ineffective paravertebral or&#xD;
      epidural block.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Pain visual analog scale is used to assess the severity of postoperative pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of postoperative analgesia</measure>
    <time_frame>for 12 hours after surgery</time_frame>
    <description>period from completion of the block to time of administration of the first rescue analgesic for 12 hour after performing the block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative postoperative meperidine consumption</measure>
    <time_frame>for 48 hours after surgery</time_frame>
    <description>Cumulative consumption of rescue meperidine analgesic for 24 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Modified Radical Mastectomy</condition>
  <arm_group>
    <arm_group_label>Thoracic Paravertebral group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound guided thoracic paravertebral block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pecs II group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided Pecs II block</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thoracic Paravertebral group</intervention_name>
    <description>Thoracic paravertebral block is performed using bupivacaine 0.25% in a total volume of 30 ml</description>
    <arm_group_label>Thoracic Paravertebral group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pecs II group</intervention_name>
    <description>Ultrasound guided ipsilateral Pecs II block is performed using bupivacaine 0.25% in a total volume of 30 ml</description>
    <arm_group_label>Pecs II group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Association for Anesthesiologists physical status I or II&#xD;
&#xD;
          -  Body mass index &gt; 40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Severe or uncompensated cardiovascular disease.&#xD;
&#xD;
          -  Significant renal disease.&#xD;
&#xD;
          -  Significant hepatic disease.&#xD;
&#xD;
          -  Significant endocrinal disease.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Postpartum period.&#xD;
&#xD;
          -  Lactating females.&#xD;
&#xD;
          -  Allergy to any of the study medication.&#xD;
&#xD;
          -  Coagulation disorders.&#xD;
&#xD;
          -  Infection at the site of needle insertion.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abd-Elaziz Metawa, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesia, Surgical Intensive Care and Pain Medicine, College of Medicine, Mansoura University, Mansoura, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mansoura university</name>
      <address>
        <city>Mansoura</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>July 16, 2016</study_first_submitted>
  <study_first_submitted_qc>July 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>July 16, 2016</last_update_submitted>
  <last_update_submitted_qc>July 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

